Clinical Trials Directory

Trials / Conditions / Plasma Cell Neoplasm

Plasma Cell Neoplasm

25 registered clinical trials studyying Plasma Cell Neoplasm — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell
NCT05336383
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingCOM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
NCT04354246
Compugen LtdPhase 1
CompletedInfluenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
NCT04080531
Emory UniversityPhase 4
UnknownA Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
NCT03999697
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1
CompletedShorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malig
NCT02556931
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
WithdrawnMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
NCT01558778
Roswell Park Cancer InstituteN/A
CompletedProlonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
NCT01484015
Wake Forest University Health SciencesPhase 1
CompletedA Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermin
NCT01219010
Janssen Research & Development, LLCPhase 1
CompletedSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
National Cancer Institute (NCI)Phase 1
CompletedSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignanc
NCT00891137
Cellerant TherapeuticsPhase 1
TerminatedLenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfun
NCT00790842
PrECOG, LLC.Phase 1 / Phase 2
CompletedS0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
NCT00874211
SWOG Cancer Research Network—
CompletedBiomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
NCT01132833
UNC Lineberger Comprehensive Cancer Center—
CompletedVorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00729118
Ohio State University Comprehensive Cancer CenterPhase 1
CompletedHuman Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
NCT00547365
University of TennesseePhase 1 / Phase 2
CompletedT-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
NCT00602693
Masonic Cancer Center, University of MinnesotaPhase 1
CompletedHigh-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in T
NCT00536601
Roswell Park Cancer InstituteN/A
CompletedS0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage
NCT00064038
SWOG Cancer Research NetworkPhase 3
CompletedEpoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma
NCT00400686
The Cleveland ClinicN/A
CompletedIce Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autolo
NCT00118339
Fred Hutchinson Cancer CenterN/A
CompletedDonor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
NCT00053196
Alliance for Clinical Trials in OncologyPhase 2
TerminatedAllogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT00303719
Masonic Cancer Center, University of MinnesotaPhase 2
CompletedPeripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT00028600
Alliance for Clinical Trials in OncologyPhase 2
Terminated2nd Autologous Stem Cell Transplant in Patients With Persistent/Recurrent (AL) Amyloidosis
NCT00075608
Boston Medical CenterPhase 2
CompletedCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00005792
H. Lee Moffitt Cancer Center and Research InstitutePhase 1